Pappas Capital LLC
02/28/2011 | Press release | Archived content
Daiichi Sankyo to Acquire Plexxikon
News | 02. 28. 2011
Plexxikon
Deal Accelerates Expansion of Oncology Franchise
Berkeley, CA-February 28, 2011 - Plexxikon Inc. today announced it has entered into a merger agreement with Daiichi Sankyo Company, Limited, a Japan‐based global pharmaceutical company. The purchase price for Plexxikon is $805 million up‐front. Near‐term milestone payments associated with the approval of PLX4032 could total an additional $130 million. Closure of the transaction is subject to clearance under the Hart‐Scott‐Rodino (HSR) Antitrust Improvements Act and customary closing conditions.
Pappas Capital LLC published this content on February 28, 2011, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 22, 2026 at 10:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]